retatrutide trials results Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial Retatrutide yields results similar to
Description
In particular, dose adjustments may be warranted in those taking diuretics or other agents that influence fluid balance to minimize the risk of hypotension or volume depletion
Notice how modest this list is
If you are of Asian descent and your BMI falls between 23 and 30, have a detailed conversation with your provider about ethnicity-adjusted risk assessment
Currently, some GLP-1RAs require daily injections, which can be inconvenient for patients
